Sara Melzi

586 total citations
10 papers, 377 citations indexed

About

Sara Melzi is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Sara Melzi has authored 10 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in Sara Melzi's work include HIV/AIDS Research and Interventions (8 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (5 papers). Sara Melzi is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (5 papers). Sara Melzi collaborates with scholars based in Italy, United Kingdom and United States. Sara Melzi's co-authors include Antonella d’Arminio Monforte, Mauro Zaccarelli, Maria Paola Trotta, Adriana Ammassari, Andrea Antinori, Teresa Bini, Marco Bongiovanni, María Stella Mura, Andrea De Luca and Paola Cicconi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of General Internal Medicine and Bone.

In The Last Decade

Sara Melzi

10 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Melzi Italy	9	270	154	153	59	43	10	377
Robin L. Fisher United States	7	332 1.2×	254 1.6×	269 1.8×	59 1.0×	8 0.2×	8	440
Fátima Brañas Spain	14	156 0.6×	61 0.4×	246 1.6×	110 1.9×	58 1.3×	30	472
Michael Aboud United Kingdom	13	950 3.5×	703 4.6×	407 2.7×	172 2.9×	27 0.6×	31	1.1k
K. Anastos United States	5	259 1.0×	62 0.4×	166 1.1×	87 1.5×	2 0.0×	5	363
Katherine W. Kooij Canada	12	234 0.9×	122 0.8×	351 2.3×	133 2.3×	29 0.7×	29	485
M. Holloway United States	2	161 0.6×	118 0.8×	347 2.3×	84 1.4×	12 0.3×	2	412
Luigi Pusterla Italy	7	245 0.9×	138 0.9×	144 0.9×	92 1.6×	23 0.5×	8	366
Isabelle Rouanet France	8	236 0.9×	87 0.6×	192 1.3×	153 2.6×	9 0.2×	18	479
Marilyn McMurchie Australia	6	297 1.1×	241 1.6×	94 0.6×	84 1.4×	12 0.3×	11	447
Lisa Hamzah United Kingdom	13	430 1.6×	139 0.9×	289 1.9×	142 2.4×	8 0.2×	42	531

Countries citing papers authored by Sara Melzi

Since Specialization

Citations

This map shows the geographic impact of Sara Melzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Melzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Melzi more than expected).

Fields of papers citing papers by Sara Melzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Melzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Melzi. The network helps show where Sara Melzi may publish in the future.

Co-authorship network of co-authors of Sara Melzi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Melzi. A scholar is included among the top collaborators of Sara Melzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Melzi. Sara Melzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Melzi, Sara, Laura Carenzi, Maria Vittoria Cossu, et al.. (2010). Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems. SHILAP Revista de lepidopterología. 2010. 1–13. 20 indexed citations

2.

Madeddu, Giordano, Paolo Bonfanti, Giuseppe Vittorio De Socio, et al.. (2007). Tenofovir renal safety in HIV-infected patients: Results from the SCOLTA Project. Biomedicine & Pharmacotherapy. 62(1). 6–11. 52 indexed citations

3.

Madeddu, Giordano, Tiziana Quirino, Silvia Carradori, et al.. (2006). [Renal toxicity in HIV-infected patients receiving HAART including tenofovir].. PubMed. 14(3). 125–34. 6 indexed citations

4.

Fausto, Alfonso, Marco Bongiovanni, Paola Cicconi, et al.. (2005). Potential predictive factors of osteoporosis in HIV-positive subjects. Bone. 38(6). 893–897. 74 indexed citations

5.

Murri, Rita, Adriana Ammassari, Maria Paola Trotta, et al.. (2004). Patient-reported and physician-estimated adherence to HAART. Journal of General Internal Medicine. 19(11). 1104–1110. 50 indexed citations

6.

Trotta, Maria Paola, Adriana Ammassari, Alessandro Cozzi‐Lepri, et al.. (2003). Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens. AIDS. 17(7). 1099–1102. 55 indexed citations

7.

Chiesa, Elisabetta, Teresa Bini, Fulvio Adorni, et al.. (2003). Simplification of Protease Inhibitor-Containing Regimens with Efavirenz, Nevirapine or Abacavir: Safety and Efficacy Outcomes. Antiviral Therapy. 8(1). 27–35. 13 indexed citations

8.

Trotta, Maria Paola, Adriana Ammassari, Sara Melzi, et al.. (2002). Treatment-Related Factors and Highly Active Antiretroviral Therapy Adherence. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31. S128–S131. 65 indexed citations

9.

Bini, Teresa, Letizia Testa, Elisabetta Chiesa, et al.. (2000). Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 115–122. 30 indexed citations

10.

Bini, Teresa, Letizia Testa, Elisabetta Chiesa, et al.. (2000). Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 115–122. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact